论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
乙型病毒性肝炎男性患者累及乳腺、脾脏和骨的弥漫性大 B 细胞淋巴瘤(三重表达)的治疗:一罕见病例报告
Authors Zhou W , Gao Q , Wang L, Li W, He C, Li Y, Feng L, Liu W, Liu L, Wang Y
Received 17 July 2023
Accepted for publication 30 August 2023
Published 6 September 2023 Volume 2023:15 Pages 983—988
DOI https://doi.org/10.2147/CMAR.S427217
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Harikrishna Nakshatri
Background: Diffuse large B-cell lymphoma (DLBCL) involving the breast, spleen, and bone in a male patient with hepatitis B virus (HBV) infection is extremely rare in clinical practice.
Case Presentation: We report a case of DLBCL involving the breast, spleen, and bone (triple expression of Bcl-2+, Bcl-6+, and 70% positive C-mcy) in a male patient with HBV admitted to our hospital. The patient was treated with EPOCH× 4, lenalidomide+EPOCH× 2 chemotherapy, intermittent methotrexate intrathecal injections to prevent central invasion, and autologous stem cell transplantation (ASCT). The patient is currently in complete remission, and the follow-up time was 43 months.
Conclusion: A patient with DLBCL involving the breast, spleen, and bone can be treated with a combination of multiple regimens. If the patient’s economic conditions permit it, ASCT can be considered.
Keywords: breast, viral hepatitis B, diffuse large B-cell lymphoma, triple expression, autologous stem cell transplantation